These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25408112)

  • 21. Circulating angiopoietins and cardiovascular mortality in cardiogenic shock.
    Link A; Pöss J; Rbah R; Barth C; Feth L; Selejan S; Böhm M
    Eur Heart J; 2013 Jun; 34(22):1651-62. PubMed ID: 23349297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Canova P; Mastropasqua F; Frigerio M; Lagioia R; Oliva F
    J Heart Lung Transplant; 2014 Apr; 33(4):404-11. PubMed ID: 24485712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of change in red cell distribution width 1 month after discharge in acute decompensated heart failure patients.
    Oh J; Kang SM; Won H; Hong N; Kim SY; Park S; Lee SH; Jang Y; Chung N
    Circ J; 2012; 76(1):109-16. PubMed ID: 22033347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
    Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
    Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death].
    Mazovets OL; Trifonov IR; Katrukha AG; Bereznikova AV; Medvedeva MV; Deev AD; Gratsianksiĭ NA
    Kardiologiia; 2008; 48(1):24-9. PubMed ID: 18260992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock--a biomarker substudy of the IABP-SHOCK II-Trial.
    Pöss J; Fuernau G; Denks D; Desch S; Eitel I; de Waha S; Link A; Schuler G; Adams V; Böhm M; Thiele H
    Eur J Heart Fail; 2015 Nov; 17(11):1152-60. PubMed ID: 26333723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of N-terminal pro brain natriuretic peptide in predicting acute kidney injury in patients with acute decompensated chronic heart failure].
    Menzorov MV; Shutov AM; Midlenko VI; Larionova NV; Morozova IV; Akulova OV
    Ter Arkh; 2017; 89(3):78-84. PubMed ID: 28378735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiopoietin-2, a regulator of vascular permeability in inflammation, is associated with persistent organ failure in patients with acute pancreatitis from the United States and Germany.
    Whitcomb DC; Muddana V; Langmead CJ; Houghton FD; Guenther A; Eagon PK; Mayerle J; Aghdassi AA; Weiss FU; Evans A; Lamb J; Clermont G; Lerch MM; Papachristou GI
    Am J Gastroenterol; 2010 Oct; 105(10):2287-92. PubMed ID: 20461065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of serum cystatin C and N-terminal pro b-type natriuretic peptide in patients with acute heart failure.
    Pérez-Calvo JI; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Manzano-Fernández S; Galisteo-Almeda L; Pascual-Figal D
    Eur J Intern Med; 2012 Oct; 23(7):599-603. PubMed ID: 22939803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months].
    Mazovets OL; Trifonov IR; Katrukha AG; Gratsianskiĭ NA
    Kardiologiia; 2009; 49(1):34-8. PubMed ID: 19166399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
    Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-type natriuretic peptide. Guided vs. conventional care in outpatients with chronic heart failure: a retrospective study.
    De Vecchis R; Esposito C; Di Biase G; Ariano C
    Minerva Cardioangiol; 2013 Aug; 61(4):437-49. PubMed ID: 23846010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.
    Valle R; Aspromonte N; Milani L; Peacock FW; Maisel AS; Santini M; Ronco C
    Heart Fail Rev; 2011 Nov; 16(6):519-29. PubMed ID: 21604179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.
    Metra M; Nodari S; Parrinello G; Specchia C; Brentana L; Rocca P; Fracassi F; Bordonali T; Milani P; Danesi R; Verzura G; Chiari E; Dei Cas L
    Eur J Heart Fail; 2007 Aug; 9(8):776-86. PubMed ID: 17573240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serial Measurement of Amino-Terminal Pro-B-Type Natriuretic Peptide Predicts Adverse Cardiovascular Outcome in Children With Primary Myocardial Dysfunction and Acute Decompensated Heart Failure.
    Medar SS; Hsu DT; Ushay HM; Lamour JM; Cohen HW; Killinger JS
    Pediatr Crit Care Med; 2015 Jul; 16(6):529-34. PubMed ID: 25856472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
    Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
    Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiopoietin-2 in adults with congenital heart disease and heart failure.
    Lukasz A; Beutel G; Kümpers P; Denecke A; Westhoff-Bleck M; Schieffer B; Bauersachs J; Kielstein JT; Tutarel O
    PLoS One; 2013; 8(6):e66861. PubMed ID: 23826161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.